Two Seas Capital’s Indivior Pharmaceuticals INDV Stock Holding History

Two Seas Capital’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$132M	Buy	3,671,072 +191,579	+6%	+$7.23M	1.52%	10
2026 Q2	$143M	Sell	3,479,493 -1,267,017	-27%	-$46M	2.83%	8
2026 Q1	$145M	Sell	4,746,510 -362,688	-7%	-$12M	2.02%	8
2025 Q4	$183M	Sell	5,109,198 -5,394,954	-51%	-$165M	3.78%	5
2025 Q3	$253M	Sell	10,504,152 -903,643	-8%	-$18.9M	4.07%	4
2025 Q2	$168M	Buy	11,407,795 +41,018	+0.4%	+$478K	2.82%	4
2025 Q1	$107M	Sell	11,366,777 -1,090,737	-9%	-$11.5M	3.36%	4
2024 Q4	$155M	Sell	12,457,514 -572,513	-4%	-$5.89M	13.38%	1
2024 Q3	$127M	Buy	13,030,027 +400,001	+3%	+$4.68M	20.58%	1
2024 Q2	$204M	Sell	12,630,026 -620,976	-5%	-$11.2M	33.09%	1
2024 Q1	$284M	Sell	13,251,002 -559,891	-4%	-$10.5M	55.6%	1
2023 Q4	$211M	Buy	13,810,893 +140,581	+1%	+$2.5M	51.5%	1
2023 Q3	$315M	Buy	13,670,312 +1,393	+0%	+$31.8K	63.41%	1
2023 Q2	$325M	Buy	+13,668,919	New	+$313M	71.11%	1

Other funds holding INDV

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

SBWIC

Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

DCM

Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Two Seas Capital's INDV Position: Q3 2026 in Review

Two Seas Capital increased its Indivior Pharmaceuticals (INDV) stake by 5.5% in Q3 2026, buying an estimated $7.23M and bringing the position to 3,671,072 shares worth $132M. The position accounts for 1.52% of the portfolio, ranked #10.

Two Seas Capital first reported a position in INDV in Q2 2023 and has held it in 14 quarters since. The position peaked at $325M in Q2 2023. 9 funds tracked by Wall St. Rank hold INDV as of Q3 2026.

Two Seas Capital held 3,671,072 shares of Indivior Pharmaceuticals worth $132M as of Q3 2026.
Two Seas Capital bought 191,579 Indivior Pharmaceuticals shares in Q3 2026, an estimated $7.23M.
Indivior Pharmaceuticals made up 1.52% of Two Seas Capital's portfolio in Q3 2026, its #10 holding.
Two Seas Capital first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
Two Seas Capital's Indivior Pharmaceuticals position peaked at $325M in Q2 2023.
9 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2026.

Based on Two Seas Capital's 13F filing for Q3 2026, filed 6 Oct 2026.